A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia

NCT07550387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

SCHIZOPHRENIA 1 (Disorder)

Interventions

DRUG: HS-10380 Low Dose
DRUG: HS-10380 Medium dose
DRUG: HS-10380 High Dose
DRUG: Aripiprazole
DRUG: Placebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.